CoreSpiron Launches China's First Non-Invasive Continuous Respiratory Monitoring System, Marking a New Era in Respiratory Care

Recently, the R&D and production by Dingrui ChuangzhiNon-invasive Dynamic Respiratory MonitorandDisposable Pulmonary Electrode SensorApproved for market launch by the Henan Provincial Medical Products Administration (Registration Certificate No.: Yu Xie Zhu Zhun 20222070066, Yu Xie Zhu Zhun 20222070050)This non-invasive dynamic respiratory monitor is the first product in China capable of providing precise and continuous monitoring of pulmonary ventilation for anesthetized patients without endotracheal intubation. It enables real-time, accurate monitoring of Minute Ventilation (MV), Tidal Volume (TV), and Respiratory Rate (RR) for such patients. Currently, there are no other competing products of its kind available in the domestic market.

Dr. Yang Weiping, Founder and Chairman of the BoardIndicates:“The non-invasive dynamic respiratory monitor enables non-invasive, dynamic, and continuous monitoring of minute ventilation (MV), the most direct indicator of respiratory function. It is as easy to use as an electrocardiogram (ECG) and is suitable for preoperative assessment, intraoperative real-time monitoring, real-time monitoring during postoperative medication administration, post-anesthesia respiratory monitoring, and respiratory monitoring in critically ill patients. We are filled with expectation and confidence regarding the expansion of its applications in the domestic market, with the ultimate goal of equipping every hospital bed that has ECG monitoring with our respiratory monitoring system.”

1、Quickly Obtain Monitoring Values: The non-invasive dynamic respiratory monitor continuously monitors the patient's minute ventilation through patented non-invasive monitoring technology, obtains real-time monitoring data, and thereby provides objective data support for clinical diagnostic decision-making;

2、Accurate Monitoring Data: Compared with the gold standard of spirometry, the non-invasive dynamic respiratory monitor achieved an accuracy rate of 93% for minute ventilation monitoring and 98% for respiratory rate monitoring;

3、High Patient Compliance: No need for endotracheal intubation; the single-use disposable patch reduces the risk of cross-infection, offers simpler and more convenient operation, and is user-friendly in clinical practice.

Dingrui Chuangzhi was established in 2017 as a high-tech Sino-foreign joint venture driven fundamentally by innovative technologies and products. The company holds domestically leading independent intellectual property rights in respiratory monitoring and anesthesia. Headquartered in the Central Plains region, the company has strategically positioned itself across China, committing to becoming a leading domestic medical device enterprise in the fields of respiration and anesthesia through continuous independent innovation. Its core team comprises seasoned returnees from the United States and American technical experts, bringing extensive experience in product R&D management, corporate operations, and capital management.

Dr. Yang Weiping, Founder and Chairman of the BoardWith over 30 years of industrial experience in China and the United States, Dr. Yang is a leading expert in the fields of medical devices and clinical diagnostics, as well as a specially appointed professor at the Institute of Hepatology, Capital Medical University. In addition to his profound background in biomedical education and R&D, Dr. Yang has successfully founded multiple medical device companies since returning to China more than a decade ago, making him a rare hybrid entrepreneur with comprehensive expertise in the healthcare industry.

Dr. Chunyuan Qiu, Chief Scientific Officer of the CompanyAn international expert in the field of Anesthesiology and Perioperative Surgical Home (PSH) medicine, Chair of the Medical Performance Improvement Committee at Kaiser Permanente’s Baldwin Park Medical Center in California, Professor in the Department of Anesthesiology at the University of California, Irvine School of Medicine, and former President of the American Association of Medical Professors.

The approval of the non-invasive dynamic respiratory monitoring system not only signifies further recognition of the product’s innovativeness and clinical application value, but also indicates that this innovative technology will soon benefit patients in China.